Albumin disposition in critically Ill patients

Research output: Contribution to journalArticle

Abstract

What is known and Objective: The purpose of this critical narrative review is to analyse studies evaluating the disposition of albumin in critically ill patients and to compare the findings to studies involving healthy subjects and less severely ill patients. Comment: PubMed and EMBASE were reviewed for prospective studies involving the disposition of radiolabelled albumin. Studies of normal volunteers, patients undergoing surgical procedures and critically ill patients indicate a relationship between increasing disease acuity or severity and increasing transcapillary escape of albumin. In the only study that directly compared the disposition of radiolabelled albumin in healthy subjects and patients with septic shock, the transcapillary escape rate of albumin was more than twice as rapid in the patients with shock. What is new and Conclusion: Limited studies suggest that increasing disease severity increases transcapillary escape of albumin. Only one study compared the disposition of radiolabelled albumin in healthy subjects and critically ill patients. More studies are needed in subsets of critically ill patients.

Original languageEnglish (US)
JournalJournal of Clinical Pharmacy and Therapeutics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Critical Illness
Albumins
Healthy Volunteers
Septic Shock
PubMed
Shock
Prospective Studies

Keywords

  • Albumin
  • Disposition
  • Distribution
  • Half-life
  • Pharmacokinetics
  • Transcapillary escape rate

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Albumin disposition in critically Ill patients. / Erstad, Brian L.

In: Journal of Clinical Pharmacy and Therapeutics, 01.01.2018.

Research output: Contribution to journalArticle

@article{fa0c59eb9f8743699f48712115829dc2,
title = "Albumin disposition in critically Ill patients",
abstract = "What is known and Objective: The purpose of this critical narrative review is to analyse studies evaluating the disposition of albumin in critically ill patients and to compare the findings to studies involving healthy subjects and less severely ill patients. Comment: PubMed and EMBASE were reviewed for prospective studies involving the disposition of radiolabelled albumin. Studies of normal volunteers, patients undergoing surgical procedures and critically ill patients indicate a relationship between increasing disease acuity or severity and increasing transcapillary escape of albumin. In the only study that directly compared the disposition of radiolabelled albumin in healthy subjects and patients with septic shock, the transcapillary escape rate of albumin was more than twice as rapid in the patients with shock. What is new and Conclusion: Limited studies suggest that increasing disease severity increases transcapillary escape of albumin. Only one study compared the disposition of radiolabelled albumin in healthy subjects and critically ill patients. More studies are needed in subsets of critically ill patients.",
keywords = "Albumin, Disposition, Distribution, Half-life, Pharmacokinetics, Transcapillary escape rate",
author = "Erstad, {Brian L}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/jcpt.12742",
language = "English (US)",
journal = "Journal of Clinical Pharmacy and Therapeutics",
issn = "0269-4727",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Albumin disposition in critically Ill patients

AU - Erstad, Brian L

PY - 2018/1/1

Y1 - 2018/1/1

N2 - What is known and Objective: The purpose of this critical narrative review is to analyse studies evaluating the disposition of albumin in critically ill patients and to compare the findings to studies involving healthy subjects and less severely ill patients. Comment: PubMed and EMBASE were reviewed for prospective studies involving the disposition of radiolabelled albumin. Studies of normal volunteers, patients undergoing surgical procedures and critically ill patients indicate a relationship between increasing disease acuity or severity and increasing transcapillary escape of albumin. In the only study that directly compared the disposition of radiolabelled albumin in healthy subjects and patients with septic shock, the transcapillary escape rate of albumin was more than twice as rapid in the patients with shock. What is new and Conclusion: Limited studies suggest that increasing disease severity increases transcapillary escape of albumin. Only one study compared the disposition of radiolabelled albumin in healthy subjects and critically ill patients. More studies are needed in subsets of critically ill patients.

AB - What is known and Objective: The purpose of this critical narrative review is to analyse studies evaluating the disposition of albumin in critically ill patients and to compare the findings to studies involving healthy subjects and less severely ill patients. Comment: PubMed and EMBASE were reviewed for prospective studies involving the disposition of radiolabelled albumin. Studies of normal volunteers, patients undergoing surgical procedures and critically ill patients indicate a relationship between increasing disease acuity or severity and increasing transcapillary escape of albumin. In the only study that directly compared the disposition of radiolabelled albumin in healthy subjects and patients with septic shock, the transcapillary escape rate of albumin was more than twice as rapid in the patients with shock. What is new and Conclusion: Limited studies suggest that increasing disease severity increases transcapillary escape of albumin. Only one study compared the disposition of radiolabelled albumin in healthy subjects and critically ill patients. More studies are needed in subsets of critically ill patients.

KW - Albumin

KW - Disposition

KW - Distribution

KW - Half-life

KW - Pharmacokinetics

KW - Transcapillary escape rate

UR - http://www.scopus.com/inward/record.url?scp=85050700541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050700541&partnerID=8YFLogxK

U2 - 10.1111/jcpt.12742

DO - 10.1111/jcpt.12742

M3 - Article

JO - Journal of Clinical Pharmacy and Therapeutics

JF - Journal of Clinical Pharmacy and Therapeutics

SN - 0269-4727

ER -